| [1] |
Razumilava N, Gores GJ. Cholangiocarcinoma[J]. The Lancet，2014，383(9935):2168-2179.
|
| [2] |
Banales JM, Cardinale V, Carpino G，et al. Expert consensus document：Cholangiocarcinoma：current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma（ENS-CCA）[J]. Nat Rev Gastroenterol Hepatol，2016，13(5):261-280.
|
| [3] |
Bismuth H, Castaing D, Traynor O. Resection or palliation：priority of surgery in the treatment of hilar cancer[J]. World J Surg，1988，12(1):39-47.
|
| [4] |
Khan SA, Thomas HC, Davidson BR，et al. Cholangiocarcinoma[J]. The Lancet，2005，366(9493):1303-1314.
|
| [5] |
Larghi A, Tringali A, Lecca PG，et al. Management of hilar biliary strictures[J]. Am J Gastroenterol，2008，103(2):458-473.
|
| [6] |
Speer AG, Cotton PB, Russell RC，et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice[J]. Lancet，1987，2(8550):57-62.
|
| [7] |
Kim JH. Endoscopic stent placement in the palliation of malignant biliary obstruction[J]. Clin Endosc，2011，44(2):76-86.
|
| [8] |
Kanasaki S, Furukawa A, Kane T，et al. Polyurethane-covered Nitinol Strecker stents as primary palliative treatment of malignant biliary obstruction[J]. Cardiovasc Intervent Radiol，2000，23(2):114-120.
|
| [9] |
Almadi M A, Barkun AN, Martel M. No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction：a meta-analysis[J]. Clin Gastroenterol Hepatol，2013，11(1):27-37.
|
| [10] |
Yang MJ, Kim JH, Yoo BM，et al. Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction：A randomized controlled trial[J]. Scand J Gastroenterol，2015，50(12):1490-1499.
|
| [11] |
隋守光，王滨，曹贵文. 192Ir胆道腔内放射在肝门部胆管癌治疗中的应用[J].潍坊医学院学报，2007，29(1):91-94.
|
| [12] |
李文会，罗剑钧，戴真煜，等.腔内近距离放疗联合及支架植入治疗恶性胆道梗阻[J].介入放射学杂志，2015，24(3):215-218.
|
| [13] |
Takahashi Y, Ito A, Sumida I，et al. Dosimetric consideration of individual 125I source strength measurement and a large-scale comparison of that measured with a nominal value in permanent prostate implant brachytherapy[J]. Radiat Med，2006，24(10):675-679.
|
| [14] |
Wang ZM, Liu Y, Liu FJ，et al. Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer[J]. Eur Radiol，2010，20(7):1786-1791.
|
| [15] |
Trombetta MG, Colonias A, Makishi D，et al. Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung[J]. Brachytherapy，2008，7(1):50-54.
|
| [16] |
Chen Y, Wang XL, Yan ZP，et al. The use of 125I seed strands for intraluminal brachytherapy of malignant obstructive jaundice[J]. Cancer Biother Radiopharm，2012，27(5):317-323.
|
| [17] |
陈旭，朱光宇，滕皋军，等.胆管内照射支架应用的实验研究[J].介入放射学杂志，2012，21(5):399-404.
|
| [18] |
郭金和，朱光宇，朱海东，等.胆管内照射支架的研制及临床应用的初步结果[J].中华医学杂志，2011，91(33):2310-2313.
|
| [19] |
Zhu HD, Guo JH, Zhu GY，et al. A novel biliary stent loaded with （125）I seeds in patients with malignant biliary obstruction：preliminary results versus a conventional biliary stent[J]. J Hepatol，2012，56(5):1104-1111.
|
| [20] |
Zhu HD, Guo JH, Huang M，et al. Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction：A multicenter trial[J]. J Hepatol，2018，68(5):970-977.
|
| [21] |
Lee DK. Drug-eluting stent in malignant biliary obstruction[J]. J Hepatobiliary Pancreat Surg，2009，16(5):628-632.
|
| [22] |
张明明，肖宏生，沈洋，等.丝裂霉素C药物洗脱支架用于胆管良性狭窄治疗的实验研究[J].中华消化内镜杂志，2013，30(7):389-393.
|
| [23] |
张明明.曲安奈德胆管洗脱支架的制作及其在胆管良性狭窄中的应用[D].苏州：苏州大学，2013.
|
| [24] |
Lee SS, Shin JH, Han JM，et al. Histologic influence of paclitaxel-eluting covered metallic stents in a canine biliary model[J]. Gastrointest Endosc，2009，69(6):1140-1147.
|
| [25] |
Song TJ, Lee SS, Yun SC，et al. Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction：A prospective comparative pilot study[J]. Gastrointest Endosc，2011，73(4):727-733.
|
| [26] |
Jang SI, Kim JH, Kim M，et al. Porcine feasibility and safety study of a new paclitaxel-eluting biliary stent with a Pluronic-containing membrane[J]. Endoscopy，2012，44(9):825-831.
|
| [27] |
周瑜，吴志远，丁晓毅.不可逆电穿孔消融治疗胰腺癌的现状与展望[J].中华介入放射学电子杂志，2017，5(3):194-198.
|
| [28] |
Li X, Fan WJ, Zhang L，et al. CT-guided percutaneous microwave ablation of adrenal malignant carcinoma：preliminary results[J]. Cancer，2011，117(22):5182-5188.
|
| [29] |
Wang JF, Zhao LZ, Zhou CG，et al. Percutaneous intraductal radiofrequency ablation combined with biliary stent placement for nonresectable malignant biliary obstruction improves stent patency but not survival[J]. Medicine（Baltimore），2016，95(15):e3329.
|
| [30] |
Duan XH, Wang YL, Han XW，et al. Intraductal radiofrequency ablation followed by locoregional tumor treatments for treating occluded biliary stents in non-resectable malignant biliary obstruction：A single-institution experience[J]. PLoS One，2015，10(8):e0134857.
|
| [31] |
Steel AW, Postgate AJ, Khorsandi S，et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction[J]. Gastrointest Endosc，2011，73(1):149-153.
|
| [32] |
Mizandari M, Kumar J, Pai M，et al. Interventional radiofrequency ablation：A promising therapeutic modality in the management of malignant biliary and pancreatic duct obstruction[J]. J Cancer，2018，9(4):629-637.
|
| [33] |
Hansler J, Wissniowski TT, Schuppan D，et al. Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases[J]. World J Gastroenterol，2006，12(23):3716-3721.
|
| [34] |
Strand DS, Cosgrove ND, Patrie JT，et al. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma[J]. Gastrointest Endosc，2014，80(5):794-804.
|
| [35] |
Tal AO, Vermehren J, Friedrich-Rust M，et al. Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction[J]. World J Gastrointest Endosc，2014，6(1):13-19.
|
| [36] |
Tian G, Zhao QY, Chen F，et al. Ablation of hepatic malignant tumors with irreversible electroporation：A systematic review and meta-analysis of outcomes[J]. Oncotarget，2017，8(4):5853-5860.
|
| [37] |
Ueshima E, Schattner M, Mendelsohn R，et al. Transmural ablation of the normal porcine common bile duct with catheter-directed irreversible electroporation is feasible and does not affect duct patency[J]. Gastrointest Endosc，2018，87(1):300. e1-300300.e6.
|
| [38] |
Martin EK, Bhutiani N, Egger ME，et al. Safety and efficacy of irreversible electroporation in the treatment of obstructive jaundice in advanced hilar cholangiocarcinoma[J]. HPB（Oxford），2018，20(11):1092-1097.
|
| [39] |
Lee TY, Cheon YK, Shim CS，et al. Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma[J]. World J Gastroenterol，2012，18(39):5589-5594.
|
| [40] |
Moole H, Tathireddy H, Dharmapuri S，et al. Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma：A systematic review and meta-analysis[J]. World J Gastroenterol，2017，23(7):1278-1288.
|
| [41] |
Bae BC, Yang SG, Jeong S，et al. Polymeric photosensitizer-embedded self-expanding metal stent for repeatable endoscopic photodynamic therapy of cholangiocarcinoma[J]. Biomaterials，2014，35(30):8487-8495.
|